ID   LOH1_ARATH              Reviewed;         310 AA.
AC   Q9LDF2;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   07-APR-2021, entry version 124.
DE   RecName: Full=Ceramide synthase LOH1 {ECO:0000303|PubMed:25822663};
DE            Short=CS1 {ECO:0000303|PubMed:23505340};
DE            Short=CSII {ECO:0000303|PubMed:23499054};
DE            EC=2.3.1.- {ECO:0000269|PubMed:21666002, ECO:0000269|PubMed:21883234, ECO:0000269|PubMed:26635357};
DE   AltName: Full=Protein LONGEVITY ASSURANCE GENE ONE HOMOLOG 1 {ECO:0000303|PubMed:26276842};
DE            Short=LAG One Homolog 1 {ECO:0000303|PubMed:21666002};
DE            Short=LAG1 homolog 1 {ECO:0000303|PubMed:10781105};
DE            Short=LAG1 longevity assurance homolog 1 {ECO:0000303|PubMed:10781105};
GN   Name=LOH1 {ECO:0000303|PubMed:21666002, ECO:0000303|PubMed:25822663};
GN   Synonyms=LAG1 {ECO:0000303|PubMed:10781105};
GN   OrderedLocusNames=At3g25540 {ECO:0000312|Araport:AT3G25540};
GN   ORFNames=MWL2.19 {ECO:0000312|EMBL:BAB01323.1};
OS   Arabidopsis thaliana (Mouse-ear cress).
OC   Eukaryota; Viridiplantae; Streptophyta; Embryophyta; Tracheophyta;
OC   Spermatophyta; Magnoliopsida; eudicotyledons; Gunneridae; Pentapetalae;
OC   rosids; malvids; Brassicales; Brassicaceae; Camelineae; Arabidopsis.
OX   NCBI_TaxID=3702;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10781105; DOI=10.1073/pnas.97.9.4961;
RA   Brandwagt B.F., Mesbah L.A., Takken F.L.W., Laurent P.L., Kneppers T.J.A.,
RA   Hille J., Nijkamp H.J.J.;
RT   "A longevity assurance gene homolog of tomato mediates resistance to
RT   Alternaria alternata f. sp. lycopersici toxins and fumonisin B1.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:4961-4966(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=10819329; DOI=10.1093/dnares/7.2.131;
RA   Sato S., Nakamura Y., Kaneko T., Katoh T., Asamizu E., Tabata S.;
RT   "Structural analysis of Arabidopsis thaliana chromosome 3. I. Sequence
RT   features of the regions of 4,504,864 bp covered by sixty P1 and TAC
RT   clones.";
RL   DNA Res. 7:131-135(2000).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=27862469; DOI=10.1111/tpj.13415;
RA   Cheng C.Y., Krishnakumar V., Chan A.P., Thibaud-Nissen F., Schobel S.,
RA   Town C.D.;
RT   "Araport11: a complete reannotation of the Arabidopsis thaliana reference
RT   genome.";
RL   Plant J. 89:789-804(2017).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=cv. Columbia;
RX   PubMed=14593172; DOI=10.1126/science.1088305;
RA   Yamada K., Lim J., Dale J.M., Chen H., Shinn P., Palm C.J., Southwick A.M.,
RA   Wu H.C., Kim C.J., Nguyen M., Pham P.K., Cheuk R.F., Karlin-Newmann G.,
RA   Liu S.X., Lam B., Sakano H., Wu T., Yu G., Miranda M., Quach H.L.,
RA   Tripp M., Chang C.H., Lee J.M., Toriumi M.J., Chan M.M., Tang C.C.,
RA   Onodera C.S., Deng J.M., Akiyama K., Ansari Y., Arakawa T., Banh J.,
RA   Banno F., Bowser L., Brooks S.Y., Carninci P., Chao Q., Choy N., Enju A.,
RA   Goldsmith A.D., Gurjal M., Hansen N.F., Hayashizaki Y., Johnson-Hopson C.,
RA   Hsuan V.W., Iida K., Karnes M., Khan S., Koesema E., Ishida J., Jiang P.X.,
RA   Jones T., Kawai J., Kamiya A., Meyers C., Nakajima M., Narusaka M.,
RA   Seki M., Sakurai T., Satou M., Tamse R., Vaysberg M., Wallender E.K.,
RA   Wong C., Yamamura Y., Yuan S., Shinozaki K., Davis R.W., Theologis A.,
RA   Ecker J.R.;
RT   "Empirical analysis of transcriptional activity in the Arabidopsis
RT   genome.";
RL   Science 302:842-846(2003).
RN   [5]
RP   FUNCTION, DISRUPTION PHENOTYPE, TISSUE SPECIFICITY, CATALYTIC ACTIVITY, AND
RP   PATHWAY.
RC   STRAIN=cv. Columbia;
RX   PubMed=21883234; DOI=10.1111/j.1469-8137.2011.03852.x;
RA   Ternes P., Feussner K., Werner S., Lerche J., Iven T., Heilmann I.,
RA   Riezman H., Feussner I.;
RT   "Disruption of the ceramide synthase LOH1 causes spontaneous cell death in
RT   Arabidopsis thaliana.";
RL   New Phytol. 192:841-854(2011).
RN   [6]
RP   FUNCTION, DISRUPTION PHENOTYPE, CATALYTIC ACTIVITY, AND PATHWAY.
RC   STRAIN=cv. Columbia;
RX   PubMed=21666002; DOI=10.1105/tpc.110.080473;
RA   Markham J.E., Molino D., Gissot L., Bellec Y., Hematy K., Marion J.,
RA   Belcram K., Palauqui J.-C., Satiat-Jeunemaitre B., Faure J.-D.;
RT   "Sphingolipids containing very-long-chain fatty acids define a secretory
RT   pathway for specific polar plasma membrane protein targeting in
RT   Arabidopsis.";
RL   Plant Cell 23:2362-2378(2011).
RN   [7]
RP   REVIEW ON SPHINGOLIPIDS.
RX   PubMed=23505340; DOI=10.1199/tab.0161;
RA   Li-Beisson Y., Shorrosh B., Beisson F., Andersson M.X., Arondel V.,
RA   Bates P.D., Baud S., Bird D., Debono A., Durrett T.P., Franke R.B.,
RA   Graham I.A., Katayama K., Kelly A.A., Larson T., Markham J.E., Miquel M.,
RA   Molina I., Nishida I., Rowland O., Samuels L., Schmid K.M., Wada H.,
RA   Welti R., Xu C., Zallot R., Ohlrogge J.;
RT   "Acyl-lipid metabolism.";
RL   Arabidopsis Book 11:E0161-E0161(2013).
RN   [8]
RP   REVIEW ON SPHINGOLIPIDS.
RX   PubMed=23499054; DOI=10.1016/j.pbi.2013.02.009;
RA   Markham J.E., Lynch D.V., Napier J.A., Dunn T.M., Cahoon E.B.;
RT   "Plant sphingolipids: function follows form.";
RL   Curr. Opin. Plant Biol. 16:350-357(2013).
RN   [9]
RP   TISSUE SPECIFICITY.
RC   STRAIN=cv. Columbia;
RX   PubMed=25794895; DOI=10.1016/j.phytochem.2015.02.019;
RA   Luttgeharm K.D., Kimberlin A.N., Cahoon R.E., Cerny R.L., Napier J.A.,
RA   Markham J.E., Cahoon E.B.;
RT   "Sphingolipid metabolism is strikingly different between pollen and leaf in
RT   Arabidopsis as revealed by compositional and gene expression profiling.";
RL   Phytochemistry 115:121-129(2015).
RN   [10]
RP   FUNCTION, AND ACTIVITY REGULATION.
RC   STRAIN=cv. Columbia;
RX   PubMed=26276842; DOI=10.1104/pp.15.00987;
RA   Luttgeharm K.D., Chen M., Mehra A., Cahoon R.E., Markham J.E., Cahoon E.B.;
RT   "Overexpression of Arabidopsis ceramide synthases differentially affects
RT   growth, sphingolipid metabolism, programmed cell death, and mycotoxin
RT   resistance.";
RL   Plant Physiol. 169:1108-1117(2015).
RN   [11]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RC   STRAIN=cv. Columbia;
RX   PubMed=25822663; DOI=10.1371/journal.pgen.1005143;
RA   Xie L.-J., Chen Q.-F., Chen M.-X., Yu L.-J., Huang L., Chen L., Wang F.-Z.,
RA   Xia F.-N., Zhu T.-R., Wu J.-X., Yin J., Liao B., Shi J., Zhang J.-H.,
RA   Aharoni A., Yao N., Shu W., Xiao S.;
RT   "Unsaturation of very-long-chain ceramides protects plant from hypoxia-
RT   induced damages by modulating ethylene signaling in Arabidopsis.";
RL   PLoS Genet. 11:e1005143-e1005143(2015).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND PATHWAY.
RX   PubMed=26635357; DOI=10.1042/bj20150824;
RA   Luttgeharm K.D., Cahoon E.B., Markham J.E.;
RT   "Substrate specificity, kinetic properties and inhibition by fumonisin B1
RT   of ceramide synthase isoforms from Arabidopsis.";
RL   Biochem. J. 473:593-603(2016).
RN   [13]
RP   REVIEW.
RX   PubMed=32407692; DOI=10.1016/j.tplants.2020.03.007;
RA   Mortimer J.C., Scheller H.V.;
RT   "Synthesis and function of complex sphingolipid glycosylation.";
RL   Trends Plant Sci. 25:522-524(2020).
CC   -!- FUNCTION: Essential for plant growth, promotes cell division in root
CC       meristems (PubMed:21666002, PubMed:21883234, PubMed:26276842).
CC       Catalyzes the biosynthesis of ceramide sphingolipids with C(16) to
CC       C(28) fatty acids, structural membrane lipids involved in membrane
CC       trafficking (e.g. early endosomes) and cell polarity (e.g. polar auxin
CC       transport related peoteins); mostly active with t18:0 and saturated
CC       very long saturated fatty acids (C24:0 and C26:0), such as long-chain
CC       base (LCB) phytosphingosine (t18:0), lignoceroyl- and hexacosanoyl-CoAs
CC       (PubMed:21883234, PubMed:26635357, PubMed:21666002, PubMed:26276842).
CC       Mediates resistance to sphinganine-analog mycotoxins (SAMs, e.g.
CC       fumonisin B(1)) by restoring the sphingolipid biosynthesis (By
CC       similarity). Could salvage the transport of GPI-anchored proteins from
CC       the endoplasmic reticulum to the Golgi apparatus in ceramides-depleted
CC       cells after SAM exposure (By similarity). May prevent precocious cell
CC       death by delaying PR1 accumulation during aging (PubMed:21883234).
CC       Contributes to hypoxic conditions tolerance (e.g. submergences),
CC       especially in the dark, by promoting the formation of very-long-chain
CC       (VLC) ceramide species (22:1, 24:1 and 26:1) and of VLC unsaturated
CC       ceramides, which are modulating CTR1-mediated ethylene signaling
CC       leading to endoplasmic reticulum (ER)-to-nucleus translocation of EIN2
CC       and EIN3 (PubMed:25822663). {ECO:0000250|UniProtKB:Q9M6A3,
CC       ECO:0000269|PubMed:21666002, ECO:0000269|PubMed:21883234,
CC       ECO:0000269|PubMed:25822663, ECO:0000269|PubMed:26276842,
CC       ECO:0000269|PubMed:26635357}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4R)-hydroxysphinganine + a fatty acyl-CoA = an N-acyl-(4R)-4-
CC         hydroxysphinganine + CoA + H(+); Xref=Rhea:RHEA:35651,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:31998, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:64124, ChEBI:CHEBI:77636;
CC         Evidence={ECO:0000269|PubMed:21666002, ECO:0000269|PubMed:21883234,
CC         ECO:0000269|PubMed:26635357};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35652;
CC         Evidence={ECO:0000269|PubMed:21666002, ECO:0000269|PubMed:21883234,
CC         ECO:0000269|PubMed:26635357};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4R)-hydroxysphinganine + hexacosanoyl-CoA = CoA + H(+) + N-
CC         hexacosanoyl-(4R)-hydroxysphinganine; Xref=Rhea:RHEA:33339,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:52980, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:64124, ChEBI:CHEBI:64868;
CC         Evidence={ECO:0000269|PubMed:21666002, ECO:0000269|PubMed:21883234,
CC         ECO:0000269|PubMed:26635357};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33340;
CC         Evidence={ECO:0000269|PubMed:21666002, ECO:0000269|PubMed:21883234,
CC         ECO:0000269|PubMed:26635357};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(4R)-hydroxysphinganine + tetracosanoyl-CoA = CoA + H(+) + N-
CC         tetracosanoyl-(4R)-hydroxysphinganine; Xref=Rhea:RHEA:33595,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:52979, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:64124, ChEBI:CHEBI:65052;
CC         Evidence={ECO:0000269|PubMed:21666002, ECO:0000269|PubMed:21883234,
CC         ECO:0000269|PubMed:26635357};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33596;
CC         Evidence={ECO:0000269|PubMed:21666002, ECO:0000269|PubMed:21883234,
CC         ECO:0000269|PubMed:26635357};
CC   -!- ACTIVITY REGULATION: Inhibited by the mycotoxin fumonisin B(1), a
CC       sphingosine analog mycotoxins produced by pathogenic fungi
CC       (PubMed:26276842, PubMed:26635357). Repressed by divalent cation such
CC       as magnesium Mg(2+), copper Cu(2+), zinc Zn(2+), manganese Mn(2+),
CC       calcium Ca(2+) and cobalt Co(2+) (PubMed:26635357).
CC       {ECO:0000269|PubMed:26276842, ECO:0000269|PubMed:26635357}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=6.9 uM for phytosphingosine (t18:0) {ECO:0000269|PubMed:26635357};
CC         Vmax=273 pmol/min/mg enzyme with phytosphingosine (t18:0) as
CC         substrate {ECO:0000269|PubMed:26635357};
CC   -!- PATHWAY: Sphingolipid metabolism. {ECO:0000269|PubMed:21666002,
CC       ECO:0000269|PubMed:21883234, ECO:0000269|PubMed:26635357}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q8C172}; Multi-pass membrane protein
CC       {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Expressed ubiquitously at high levels
CC       (PubMed:21883234). Not observed in pollen (PubMed:25794895).
CC       {ECO:0000269|PubMed:21883234, ECO:0000269|PubMed:25794895}.
CC   -!- DISRUPTION PHENOTYPE: Elevated levels of free trihydroxy sphingoid
CC       bases as well as ceramide and glucosylceramide species with C(16) fatty
CC       acid, but reduced levels of species with C(20) to C(28) fatty acids
CC       (PubMed:21883234, PubMed:25822663). Spontaneous cell death accompanied
CC       by an enhanced PR1 expression at advanced age (PubMed:21883234). The
CC       double mutant loh1 loh3 is embryonically lethal (PubMed:21883234,
CC       PubMed:21666002). Rare viable loh1 loh3 seedlings have a complete
CC       absence of very-long-chain fatty acid (VLCFA) in sphingolipids and
CC       exhibit strong dwarf phenotype and altered lateral root outgrowth
CC       associated with disrupted early endosomes and an impaired polar auxin
CC       transport due to abnormal localization of auxin transporters in the
CC       plasma membrane; these phenotypes are in part restored by external
CC       auxin (NAA) (PubMed:21666002). Better resistance to submergence under
CC       light conditions, but increased sensitivity to dark submergence
CC       associated with declined levels of unsaturated very-long-chain (VLC)
CC       ceramide species (22:1, 24:1 and 26:1) (PubMed:25822663). The double
CC       mutant loh1 loh3, lacking (VLC), have an impaired tolerance to both
CC       dark and light submergences (PubMed:25822663).
CC       {ECO:0000269|PubMed:21666002, ECO:0000269|PubMed:21883234,
CC       ECO:0000269|PubMed:25822663}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF198179; AAF66102.1; -; mRNA.
DR   EMBL; AB025639; BAB01323.1; -; Genomic_DNA.
DR   EMBL; CP002686; AEE77023.1; -; Genomic_DNA.
DR   EMBL; CP002686; ANM66003.1; -; Genomic_DNA.
DR   EMBL; AF360152; AAK25862.1; -; mRNA.
DR   EMBL; AY142597; AAN13166.1; -; mRNA.
DR   RefSeq; NP_001319643.1; NM_001338755.1.
DR   RefSeq; NP_566769.1; NM_113450.5.
DR   STRING; 3702.AT3G25540.1; -.
DR   iPTMnet; Q9LDF2; -.
DR   PaxDb; Q9LDF2; -.
DR   PRIDE; Q9LDF2; -.
DR   ProteomicsDB; 237069; -.
DR   EnsemblPlants; AT3G25540.1; AT3G25540.1; AT3G25540.
DR   EnsemblPlants; AT3G25540.3; AT3G25540.3; AT3G25540.
DR   GeneID; 822140; -.
DR   Gramene; AT3G25540.1; AT3G25540.1; AT3G25540.
DR   Gramene; AT3G25540.3; AT3G25540.3; AT3G25540.
DR   KEGG; ath:AT3G25540; -.
DR   Araport; AT3G25540; -.
DR   TAIR; locus:2094528; AT3G25540.
DR   eggNOG; KOG1607; Eukaryota.
DR   HOGENOM; CLU_028277_5_0_1; -.
DR   InParanoid; Q9LDF2; -.
DR   OMA; ISISHHV; -.
DR   OrthoDB; 987268at2759; -.
DR   PhylomeDB; Q9LDF2; -.
DR   BioCyc; MetaCyc:MONOMER-20773; -.
DR   PRO; PR:Q9LDF2; -.
DR   Proteomes; UP000006548; Chromosome 3.
DR   ExpressionAtlas; Q9LDF2; baseline and differential.
DR   Genevisible; Q9LDF2; AT.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:TAIR.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:TAIR.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:TAIR.
DR   GO; GO:0016410; F:N-acyltransferase activity; IBA:GO_Central.
DR   GO; GO:0050291; F:sphingosine N-acyltransferase activity; IGI:TAIR.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0010256; P:endomembrane system organization; IMP:UniProtKB.
DR   GO; GO:2000012; P:regulation of auxin polar transport; IMP:UniProtKB.
DR   GO; GO:0006665; P:sphingolipid metabolic process; IDA:UniProtKB.
DR   GO; GO:0042761; P:very long-chain fatty acid biosynthetic process; IGI:TAIR.
DR   InterPro; IPR016439; Lag1/Lac1-like.
DR   InterPro; IPR006634; TLC-dom.
DR   PANTHER; PTHR12560; PTHR12560; 1.
DR   Pfam; PF03798; TRAM_LAG1_CLN8; 1.
DR   PIRSF; PIRSF005225; LAG1_LAC1; 1.
DR   SMART; SM00724; TLC; 1.
DR   PROSITE; PS50922; TLC; 1.
PE   1: Evidence at protein level;
KW   Endoplasmic reticulum; Lipid biosynthesis; Lipid metabolism; Membrane;
KW   Phosphoprotein; Reference proteome; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..310
FT                   /note="Ceramide synthase LOH1"
FT                   /id="PRO_0000185518"
FT   TRANSMEM        16..36
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        85..105
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        131..151
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        157..177
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        216..236
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        260..280
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          76..289
FT                   /note="TLC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00205"
FT   MOD_RES         300
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9LJK3"
FT   MOD_RES         302
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9LJK3"
SQ   SEQUENCE   310 AA;  36498 MW;  B3E1F2D5D3A4AEAD CRC64;
     MGLFESVKSI DWEQESFPTY QDLGFLPLFA VFFPTIRFLL DRFVFEKLAS LVIYGRMSTN
     KSDNIKDRKK NSPKVRKFKE SAWKCIYYLS AELLALSVTY NEPWFSNTLY FWIGPGDQIW
     PDQPMKMKLK FLYMFAAGFY TYSIFALVFW ETRRSDFGVS MGHHITTLVL IVLSYICRLT
     RAGSVILALH DASDVFLEIG KMSKYCGAES LASISFVLFA LSWVVLRLIY YPFWILWSTS
     YQIIMTVDKE KHPNGPILYY MFNTLLYFLL VLHIFWWVLI YRMLVKQVQD RGKLSEDVRS
     DSESDDEHED
//
